Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,006 public trials 571 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

A Registry Study of Participants With Multiple Myeloma in Latin America

NCT03955900

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Fundaleu Buenos Aires, Argentina
  • Hospital Italiano de Buenos Aires Buenos Aires, Argentina
  • Instituto de Oncologia Angel H. Roffo Buenos Aires, Argentina
  • Hospital Privado - Centro Medico de Cordoba Córdoba, Argentina
View all 22 locations
View Trial Details
Completed

A Study of Cobimetinib Administered as Single Agent and in Combination With Venetoclax, With or Without Atezolizumab, in Participants With Relapsed and Refractory Multiple Myeloma

NCT03312530

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Fakultni nemocnice Brno; Interni hematologicka a onkologicka klinika Brno, Czechia
  • Fakultni nemocnice Ostrava; Klinika hematoonkologie Ostrava, Czechia
  • Univerzita Karlova v Praze a Vseobecna fakultni nemocnice v Praze - 1; Lekarska Fakulta - I Prague, Czechia
  • Rigshospitalet; Hæmatologisk Klinik København Ø, Denmark
View all 26 locations
View Trial Details
Completed

A Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-079 Administered Subcutaneously as a Single Agent in Participants With Relapsed/Refractory (r/r) Multiple Myeloma (MM)

NCT03439280

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • City of Hope - Duarte Duarte, California, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Mount Sinai Hospital-The Donald H. Ruttenberg Cancer Treatment Center New York, United States
  • Weill Cornell Medical Center, Div. of Hematology Medical Oncology New York, United States
View Trial Details
Completed

Combination of Lenalidomide and Dexamethasone in Treatment of Multiple Myeloma

NCT01090089

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Universitätsklinikum Münster Münster, North Rhein Westfallen, Germany
  • Universitätsklinikum Aachen Aachen, Germany
  • Agirov Klinik Berg, Germany
  • HELIOS Klinikum Berlin-Buch Berlin, Germany
View all 31 locations
View Trial Details
Completed

Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma

NCT02278315

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Mayo Clinic Jacksonville, Florida, United States
  • Loyola University Medical Center Maywood, Illinois, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
View Trial Details
Completed

A Study of KRN125 in Patients With Multiple Myeloma and Malignant Lymphoma

NCT05007652

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Nagoya City University Hospital Nagoya, Aichi-ken, Japan
  • The Jikei University Kashiwa Hospital Kashiwa, Chiba, Japan
  • Hospital of the University of Occupational and Environmental Health Kitakyushu, Fukuoka, Japan
  • Hokkaido University Hospital of the National University Corporation Sapporo, Hokkaido, Japan
View all 21 locations
View Trial Details

Related conditions